home · filing · 0001493152-24-018329
8-K/A
filed May 9, 2024, 7:59 PM ET
ticker PRPH
CIK 0000868278
leadership
confidence high
sentiment neutral
materiality 0.55
ProPhase Labs appoints Jed Latkin as COO effective Jan 1, 2024, grants 500,000 stock options
ProPhase Labs, Inc.
Jed Latkin appointed Chief Operating Officer effective January 1, 2024.
Inducement grant of options to purchase 500,000 shares at $6.00 per share, exercisable for 7 years.
Options vest 25% immediately, then 25% on each of first three anniversaries of start date.
Grant made under Nasdaq inducement exemption, not under stockholder-approved equity plan.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Jed Latkin
Chief Operating Officer
PRPH ·
ProPhase Labs, Inc.
Effective 2024-01-01
Filed May 9, 2024, 7:59 PM ET
Mr. Latkin was appointed to serve as Chief Operating Officer of the Company, effective on January 1, 2024.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jed Latkin was appointed as Chief Operating Officer at ProPhase Labs, Inc..
Action appointed
Role Chief Operating Officer
Exact text from the filing
Mr. Latkin was appointed to serve as Chief Operating Officer of the Company, effective on January 1, 2024.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-24-018329
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.